Extensive screening of 2017 unrelated Ashkenazi Jews yielded a carrier frequency of 1 in 183, indicating that COL4A3 c.40_63del is a founder variant and may be an important cause of Alport syndrome in this population [20]. Here, COL4A3 is linked to Alport syndrome.